HighTower Advisors’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.42K Buy
+16,425
New +$15.7K ﹤0.01% 3806

Other funds holding OTLK

HighTower Advisors's OTLK Position: Q3 2026 in Review

HighTower Advisors opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 16,425 shares worth $9.42K. The stake represents ﹤0.01% of the portfolio and ranks #3806 among its holdings.

63 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • HighTower Advisors held 16,425 shares of Outlook Therapeutics worth $9.42K as of Q3 2026.
  • Outlook Therapeutics was a new HighTower Advisors position in Q3 2026.
  • Outlook Therapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3806 holding.
  • 63 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.